TipRanks
JBM (Healthcare) Ltd. (HK:2161)
:2161
Hong Kong Market
2161
JBM (Healthcare) Ltd.
RESEARCH TOOLSreports
Want to see HK:2161 full AI Analyst Report?

JBM (Healthcare) Ltd. (2161) Ratios

4 Followers

JBM (Healthcare) Ltd. Ratios

HK:2161's free cash flow for Q4 2025 was HK$0.52. For the 2025 fiscal year, HK:2161's free cash flow was decreased by HK$ and operating cash flow was HK$0.28. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.90 1.90 1.61 1.66 2.06
Quick Ratio
 1.59 1.59 1.32 1.25 1.69
Cash Ratio
 0.47 0.47 0.73 0.64 0.54
Solvency Ratio
 0.38 0.40 0.65 0.48 0.20
Operating Cash Flow Ratio
 0.59 0.59 0.81 0.86 0.47
Short-Term Operating Cash Flow Coverage
 1.32 1.32 1.51 2.69 1.00
Net Current Asset Value
HK$ -143.33MHK$ -143.33MHK$ 71.19MHK$ 791.00KHK$ -98.56M
Leverage Ratios
Debt-to-Assets Ratio
 0.22 0.22 0.11 0.10 0.16
Debt-to-Equity Ratio
 0.36 0.36 0.16 0.14 0.23
Debt-to-Capital Ratio
 0.27 0.27 0.14 0.12 0.19
Long-Term Debt-to-Capital Ratio
 0.19 0.19 0.00 0.04 0.11
Financial Leverage Ratio
 1.63 1.63 1.43 1.43 1.43
Debt Service Coverage Ratio
 2.01 2.06 1.68 2.42 1.16
Interest Coverage Ratio
 22.44 21.71 55.12 20.50 5.68
Debt to Market Cap
 0.28 0.17 0.10 0.14 0.22
Interest Debt Per Share
 0.50 0.50 0.22 0.16 0.25
Net Debt to EBITDA
 0.92 0.90 -0.11 -0.03 1.70
Profitability Margins
Gross Profit Margin
55.78%55.78%52.88%52.14%35.04%
EBIT Margin
30.85%30.40%31.46%26.74%9.15%
EBITDA Margin
35.66%36.36%38.15%34.04%20.72%
Operating Profit Margin
31.42%30.40%31.45%26.87%8.95%
Pretax Profit Margin
30.21%30.21%30.89%25.43%8.01%
Net Profit Margin
24.09%24.09%25.22%20.12%6.06%
Continuous Operations Profit Margin
25.20%25.20%25.91%21.16%5.74%
Net Income Per EBT
79.75%79.75%81.63%79.12%75.67%
EBT Per EBIT
96.16%99.39%98.21%94.65%89.48%
Return on Assets (ROA)
11.41%11.41%12.77%9.39%1.85%
Return on Equity (ROE)
18.70%18.62%18.23%13.44%2.65%
Return on Capital Employed (ROCE)
17.42%16.86%19.47%14.93%3.02%
Return on Invested Capital (ROIC)
13.34%12.91%14.46%11.60%2.19%
Return on Tangible Assets
27.87%27.87%27.18%24.24%10.53%
Earnings Yield
15.39%9.26%13.45%16.40%3.03%
Efficiency Ratios
Receivables Turnover
 3.56 3.56 5.78 5.96 3.01
Payables Turnover
 19.07 19.07 17.28 14.00 11.83
Inventory Turnover
 4.61 4.61 4.48 3.39 5.51
Fixed Asset Turnover
 4.82 4.82 4.79 4.24 2.24
Asset Turnover
 0.47 0.47 0.51 0.47 0.30
Working Capital Turnover Ratio
 2.85 4.15 4.93 4.59 2.87
Cash Conversion Cycle
 162.49 162.49 123.42 142.86 156.77
Days of Sales Outstanding
 102.44 102.44 63.11 61.21 121.38
Days of Inventory Outstanding
 79.19 79.19 81.44 107.72 66.23
Days of Payables Outstanding
 19.14 19.14 21.13 26.08 30.84
Operating Cycle
 181.62 181.62 144.55 168.93 187.61
Cash Flow Ratios
Operating Cash Flow Per Share
 0.19 0.19 0.28 0.22 0.07
Free Cash Flow Per Share
 0.15 0.15 0.25 0.20 0.06
CapEx Per Share
 0.04 0.04 0.03 0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.78 0.78 0.91 0.95 0.88
Dividend Paid and CapEx Coverage Ratio
 0.74 0.74 2.28 3.04 8.50
Capital Expenditure Coverage Ratio
 4.58 4.58 10.80 18.72 8.50
Operating Cash Flow Coverage Ratio
 0.39 0.39 1.32 1.43 0.28
Operating Cash Flow to Sales Ratio
 0.18 0.18 0.29 0.29 0.15
Free Cash Flow Yield
9.16%5.50%14.04%22.75%6.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.38 10.64 7.46 6.10 33.03
Price-to-Sales (P/S) Ratio
 1.56 2.60 1.87 1.23 2.00
Price-to-Book (P/B) Ratio
 1.21 2.01 1.36 0.82 0.88
Price-to-Free Cash Flow (P/FCF) Ratio
 10.92 18.20 7.12 4.40 15.36
Price-to-Operating Cash Flow Ratio
 8.56 14.23 6.46 4.16 13.55
Price-to-Earnings Growth (PEG) Ratio
 1.53 2.55 0.12 0.05 3.63
Enterprise Value Multiple
 5.30 8.06 4.80 3.57 11.37
Enterprise Value
 1.58B 2.45B 1.43B 788.11M 956.51M
EV to EBITDA
 5.30 8.06 4.80 3.57 11.37
EV to Sales
 1.89 2.93 1.83 1.22 2.36
EV to Free Cash Flow
 13.22 20.49 6.96 4.35 18.06
EV to Operating Cash Flow
 10.33 16.02 6.31 4.12 15.94
Tangible Book Value Per Share
 0.11 0.11 0.42 0.19 -0.14
Shareholders’ Equity Per Share
 1.32 1.32 1.32 1.10 1.04
Tax and Other Ratios
Effective Tax Rate
 0.17 0.17 0.16 0.17 0.23
Revenue Per Share
 1.02 1.02 0.95 0.73 0.45
Net Income Per Share
 0.25 0.25 0.24 0.15 0.03
Tax Burden
 0.80 0.80 0.82 0.79 0.76
Interest Burden
 0.98 0.99 0.98 0.95 0.88
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.25 0.25 0.24 0.06 0.11
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 0.01 0.00
Income Quality
 0.76 0.76 0.94 1.47 2.44
Currency in HKD